Stillwater Medical Center is the first hospital in Oklahoma to offer 3D-guided breast biopsy, an advanced, minimally invasive technique utilizing the Hologic Affirm Prone Breast Biopsy System. The Affirm Prone Biopsy System is the world’s first and only dedicated prone biopsy system to offer both 2D and 3D imaging-guided breast biopsies. Many physicians prefer to perform breast biopsies with the patient reclining comfortably in the prone position, removed from the field of view of the biopsy instruments.
The availability of 3D™ imaging for biopsy guidance facilitates the localization and accurate targeting of lesions, including those that can be challenging to detect with conventional imaging techniques. In addition, this new biopsy technology from Hologic has several key advantages over standard X-ray biopsy procedures, including faster targeting and fewer X-ray exposures, resulting in shorter patient procedure time and reduced patient dose.
“Stillwater Medical is thrilled to be able to offer this advanced technology to the women of our community, said Denise Webber, Stillwater Medical Center CEO. “This gives us the ability to biopsy small areas of interest that may not be visible using other imaging techniques and provides a significant advantage to our physicians and their patients. Stillwater Medical’s investment in this technology is another affirmation of our commitment to the early detection and diagnosis of this devastating disease.”
See the Stillwater News Press article.
